# Azithromycin for Severe Acute Malnutrition in CMAM, Nigeria

> **NCT05473234** · PHASE3 · TERMINATED · sponsor: **University of California, San Francisco** · enrollment: 310 (actual)

## Conditions studied

- Severe Acute Malnutrition

## Interventions

- **DRUG:** Azithromycin
- **DRUG:** Amoxicillin

## Key facts

- **NCT ID:** NCT05473234
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-10-06
- **Primary completion:** 2023-11-29
- **Final completion:** 2023-11-29
- **Target enrollment:** 310 (ACTUAL)
- **Why stopped:** Study was halted due to low follow-up rates and issues with data collection
- **Last updated:** 2025-02-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05473234

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05473234, "Azithromycin for Severe Acute Malnutrition in CMAM, Nigeria". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05473234. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*